Funding for this research was provided by:
U.S. Department of Defense (W911QY-19-P-0180)
Centers for Disease Control and Prevention (75D30121C10530)
U.S. Department of Agriculture (2020-33610-32483, 1006789)
Received: 17 August 2021
Accepted: 6 December 2021
First Online: 21 December 2021
: Dr. Abdennour Abbas holds equity in, and is the founder and Chief Technology Officer of, Claros Technologies Inc., which has a license from the University of Minnesota to commercialize the technology described in this manuscript. Andrew Gonzalez holds equity in, and is the Lead Materials Engineer of, Claros Technologies. Dr. John Brockgreitens holds equity in, and is the Director of Research and Development of, Claros Technologies. The University of Minnesota also has equity and royalty interests in Claros. These interests have been reviewed and managed by the University of Minnesota in accordance with its Conflict-of-Interest policies. No other authors have any conflict of interest.